Abingdon, United Kingdom

Alistair David Graham Donald


 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alistair David Graham Donald: Innovator in Histone Deacetylase Inhibitors

Introduction

Alistair David Graham Donald is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as inhibitors of histone deacetylase. With a total of four patents to his name, his work is pivotal in the treatment of cell proliferative diseases, including various forms of cancer.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Hydroxamates as inhibitors of histone deacetylase." This patent details compounds of a specific formula that are effective in inhibiting histone deacetylase activity. These compounds are particularly useful in treating cancers, showcasing the potential for significant advancements in cancer therapy. The patent outlines the structural components of these compounds, including various radicals and linkers that contribute to their efficacy.

Career Highlights

Throughout his career, Alistair has worked with prominent companies in the pharmaceutical sector. Notable among these are Chroma Therapeutics Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to refine his expertise in drug development and patenting innovative solutions for complex medical challenges.

Collaborations

Alistair has collaborated with esteemed colleagues, including Alan Hornsby Davidson and Sanjay Ratilal Patel. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic agents.

Conclusion

Alistair David Graham Donald stands out as a significant figure in the realm of biochemistry and patent innovation. His contributions to the development of histone deacetylase inhibitors are crucial for advancing cancer treatment. His work exemplifies the impact of innovative thinking in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…